The Regulatory Affairs Professionals Society (RAPS), the largest global organization for regulatory professionals in the healthcare product sector, and Eucomed, the European medical technology industry association, have joined together to provide high-quality online regulatory training to professionals throughout Europe.
The agreement will make courses and certificate programs from RAPS Online University available to Eucomed members at a 10% discount.
“We are very proud of the outstanding training our team has custom developed for regulatory and related professionals and is offered through RAPS Online University,” said RAPS Executive Director Sherry Keramidas, PhD, FASAE, CAE. “It is extremely gratifying that the leadership of a highly respected organization such as Eucomed also recognizes the value RAPS courses can offer its members.”
RAPS’ courses cover an array regulatory and business topics, from general knowledge to product- and region-specific subject matter. Regulatory professionals may take individual courses to address knowledge gaps or enhance understanding of specific areas, or they may opt to earn a certificate by completing customizable curricula of online courses.
RAPS, headquartered in the US with members and affiliates throughout the world, also recently signed an agreement with China’s State Food and Drug Administration to provide regulatory training resources, and has another training partnership in place with and the University of Shanghai for Science and Technology.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.